The neomorphic binding of mutant GlyRS to neuronal membrane proteins has been shown to be a potential mechanism for the toxic gain-of-function associated with CMT2D (He et al., 2015; Sleigh et al., 2017a). This evidence concerns the gene GARS1 and Autosomal dominant Charcot-Marie-Tooth disease type 2D.